Acquired factor V inhibitors: a systematic review
- 5 November 2010
- journal article
- review article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 31 (4) , 449-457
Abstract
The occurrence of an inhibitor against coagulation factor V (FV) is a rare but challenging condition, which may span from asymptomatic laboratory abnormalities to potentially life-threatening bleeding. The onset of FV inhibitors has been associated most frequently in the past with the patients’ exposure to topical bovine thrombin administered during surgery procedures. However, since this preparation is no longer used, in this systematic review we have only focused on non-bovine thrombin-related FV inhibitor cases.Keywords
This publication has 94 references indexed in Scilit:
- Acquired factor V inhibitorThrombosis and Haemostasis, 2009
- An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1Journal of Thrombosis and Haemostasis, 2008
- Successful treatment with rituximab in a patient with an acquired factor V inhibitorAmerican Journal of Hematology, 2007
- Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinomaInternational Journal of Laboratory Hematology, 2007
- Acquired factor V inhibitor after haematopoietic stem cell transplantationThrombosis and Haemostasis, 2007
- Identification of factor inhibitors by diagnostic haemostasis laboratoriesThrombosis and Haemostasis, 2006
- Acquired hemophilia A: A concise reviewAmerican Journal of Hematology, 2005
- Factor V inhibitorsBlood Coagulation & Fibrinolysis, 2004
- Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppressionAnnals of Hematology, 1995
- Severe bleeding caused by an inhibitor to coagulation factor VBlood Coagulation & Fibrinolysis, 1994